Anosheh Afghahi, MD, discusses biomarker testing, trial matching technology, and community-academic partnerships to improve ...

Hans Lee, MD, lays out the tradeoffs in travel, time off therapy, and who each option realistically fits when looking at CAR T-cell and bispecific therapies.

Anosheh Afghahi, MD, explains how integrated health technologies can improve clinical trial matching, efficiency, and equity.

Early remdesivir treatment was associated with lower graft loss and cardiovascular events in kidney transplant recipients, noted Nitipong Permpalung, MD, MPH.

LATITUDE PsO 3001/3002 (n = 693; n = 1108) showed ~70% of patients achieving clear or almost clear skin at week 16 versus 11% to 13% on placebo and 30% to 32% on apremilast. Depth of response was ...

Young adults with sarcoma face challenges that extend well beyond treatment, and closing gaps in research funding and specialty care could improve outcomes for this population and beyond, according to ...

Navista names Jeff Hunnicutt COO, bringing in a well-known oncology leader with experience in technology and innovation at ...

Workforce expansion authorized after the 2024 Harlem outbreak remains incomplete, with 35 staff onboard versus a planned 56, leaving gaps in inspection and response throughput. A second lethal cluster ...

Moving to a subQ formulation makes sense, if you want to be 100% convenient for patients and the centers that treat them, explains Xavier Leleu, MD, PhD.

A recent study found semaglutide more than doubled the likelihood of MASH resolution, but it did not significantly improve fibrosis. Metabolic dysfunction-associated steatotic liver disease (MASLD) ...

Alireza Atri introduces mild behavioral impairment as an early-emerging framework for behavioral changes preceding formal dementia diagnosis. Alireza Atri introduces mild behavioral impairment as an ...

In June, Moderna and Merck reported clinical trial follow-up results showing that their combination mRNA cancer vaccine and ...